{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:43:11Z","timestamp":1779936191372,"version":"3.53.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Cancer testis antigens (CTAs) are a family of proteins typically expressed in male testicles but overexpressed in various cancer cell types. Transmembrane Phosphatase with Tensin homology (TPTE) is expressed only in the testis of healthy individuals and is a member of the family of CTAs. The current study, for the first time, examined the significance of TPTE expression in prostate cancer (PCa) tissues by generating a novel antibody marker targeting TPTE protein.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Polyclonal antibodies were prepared for TPTE-p1 and TPTE-p2 peptides, which are derived from the extracellular domains of TPTE. Anti-TPTE-p2 antibody was then used to study the extent and pattern of TPTE expression in 102 PCa and 48 benign prostatic hyperplasia (BPH) tissue samples by immunohistochemistry. The viability of cancer cell lines (PC-3 and MCF-7 cells) was also evaluated in the presence of anti-TPTE-p2 antibody using the MTT test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The immunohistochemical analysis demonstrated a significant increase in cytoplasmic and membrane TPTE expression in the PCa samples compared to the BPH group (both P\u2009&lt;\u20090.0001). Cytoplasmic TPTE expression was positively correlated with Gleason score and PSA levels (P\u2009=\u20090.03 and P\u2009=\u20090.001, respectively). Significant correlations were identified between the levels of PSA and perineural invasion and the membrane expression (P\u2009=\u20090.01, P\u2009=\u20090.04, respectively). Moreover, anti-TPTE-p2 antibody inhibited PC-3 and MCF-7 cells proliferation compared to the control group for 24 h (P\u2009&lt;\u20090.001 and P\u2009=\u20090.001, respectively) as well as for 48 h (<jats:italic>P<\/jats:italic>\u2009=\u20090.001 and <jats:italic>P<\/jats:italic>\u2009=\u20090.001, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our findings indicate that increased TPTE expression is associated with progression of disease. The ability of anti-TPTE-p2 antibody to recognize and target the TPTE protein makes it a potential biomarker to assess and\/or target the PCa.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-024-05694-6","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T11:01:39Z","timestamp":1711623699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Overexpression of Transmembrane Phosphatase with Tensin homology (TPTE) in prostate cancer is clinically significant, suggesting its potential as a valuable biomarker"],"prefix":"10.1007","volume":"150","author":[{"given":"Nahid","family":"Zainodini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Abolhasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monireh","family":"Mohsenzadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad M.","family":"Farajollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Rismani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"issue":"2","key":"5694_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.30442\/ahr.0802-04-163","volume":"8","author":"CA Adepiti","year":"2022","unstructured":"Adepiti CA, Odunsi K (2022) Transmembrane Phosphatase with TEnsin Homologue (TPTE) expression in epithelial ovarian cancer. Ann Med Health Sci Res 8(2):121\u2013130. https:\/\/doi.org\/10.30442\/ahr.0802-04-163","journal-title":"Ann Med Health Sci Res"},{"issue":"9","key":"5694_CR2","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.4161\/cbt.5.9.3174","volume":"5","author":"D Atanackovic","year":"2006","unstructured":"Atanackovic D, Blum I, Cao Y et al (2006) Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma. Cancer Biol Ther 5(9):1218\u20131225. https:\/\/doi.org\/10.4161\/cbt.5.9.3174","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"5694_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/1440-1681.13605","volume":"49","author":"Z Bagherian","year":"2022","unstructured":"Bagherian Z, Mirshafiey A, Mohsenzadegan M et al (2022) Evaluation of G2013 (\u03b1-l-guluronic acid) efficacy on PC-3 cells through inhibiting the expression of inflammatory factors. Clin Exp Pharmacol Physiol 49(2):254\u2013263. https:\/\/doi.org\/10.1111\/1440-1681.13605","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"17","key":"5694_CR4","doi-asserted-by":"publisher","first-page":"15321","DOI":"10.18632\/oncotarget.4148","volume":"6","author":"N Bansal","year":"2015","unstructured":"Bansal N, Mishra PJ, Stein M et al (2015) Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells. Oncotarget 6(17):15321. https:\/\/doi.org\/10.18632\/oncotarget.4148","journal-title":"Oncotarget"},{"key":"5694_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s004399900144","volume":"105","author":"H Chen","year":"1999","unstructured":"Chen H, Rossier C, Morris MA, Scott HS et al (1999) A testis-specific gene, TPTE, encodes a putative transmembrane tyrosine phosphatase and maps to the pericentromeric region of human chromosomes 21 and 13, and to chromosomes 15, 22, and Y. Hum Genet 105:399\u2013409. https:\/\/doi.org\/10.1007\/s004399900144","journal-title":"Hum Genet"},{"issue":"2","key":"5694_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41587-021-01038-8","volume":"40","author":"C Chong","year":"2022","unstructured":"Chong C, Coukos G, Bassani-Sternberg M (2022) Identification of tumor antigens with immunopeptidomics. Nat Biotechnol 40(2):175\u2013188. https:\/\/doi.org\/10.1038\/s41587-021-01038-8","journal-title":"Nat Biotechnol"},{"issue":"1","key":"5694_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.prnil.2018.11.001","volume":"7","author":"BH Chung","year":"2019","unstructured":"Chung BH, Horie S, Chiong E (2019) The incidence, mortality, and risk factors of prostate cancer in Asian men. Prostate Int 7(1):1\u20138. https:\/\/doi.org\/10.1016\/j.prnil.2018.11.001","journal-title":"Prostate Int"},{"issue":"1","key":"5694_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MBB Culp","year":"2020","unstructured":"Culp MBB, Soerjomataram I, Efstathiou JA et al (2020) Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol 77(1):38\u201352. https:\/\/doi.org\/10.1016\/j.eururo.2019.08.005","journal-title":"Eur Urol"},{"issue":"10","key":"5694_CR9","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.3390\/genes13101692","volume":"13","author":"G D'Elia","year":"2022","unstructured":"D\u2019Elia G, Caliendo G, Tzioni MM et al (2022) Increased Risk of Hereditary Prostate Cancer in Italian Families with hereditary breast and ovarian cancer syndrome harboring mutations in BRCA and in other susceptibility genes. Genes 13(10):1692. https:\/\/doi.org\/10.3390\/genes13101692","journal-title":"Genes"},{"issue":"2","key":"5694_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.bjc.6601062","volume":"89","author":"XY Dong","year":"2003","unstructured":"Dong XY, Su YR, Qian XP et al (2003) Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patients. Br J Cancer 89(2):291\u2013297. https:\/\/doi.org\/10.1038\/sj.bjc.6601062","journal-title":"Br J Cancer"},{"issue":"8","key":"5694_CR11","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I et al (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144(8):1941\u20131953. https:\/\/doi.org\/10.1002\/ijc.31937","journal-title":"Int J Cancer"},{"issue":"1","key":"5694_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188562","volume":"1876","author":"PP Gao","year":"2021","unstructured":"Gao PP, Qi XW, Sun N et al (2021) The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer. Biochim Biophys Acta Rev Cancer 1876(1):188562. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188562","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"5694_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-015-1998-y","volume":"16","author":"MF Gjerstorff","year":"2016","unstructured":"Gjerstorff MF, Terp MG, Hansen MB et al (2016) The role of GAGE cancer\/testis antigen in metastasis: the jury is still out. BMC Cancer 16(1):1\u20134. https:\/\/doi.org\/10.1186\/s12885-015-1998-y","journal-title":"BMC Cancer"},{"issue":"3","key":"5694_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/fft2.44","volume":"1","author":"S Kamiloglu","year":"2020","unstructured":"Kamiloglu S, Sari G, Ozdal T et al (2020) Guidelines for cell viability assays. Food Front 1(3):332\u2013349. https:\/\/doi.org\/10.1002\/fft2.44","journal-title":"Food Front"},{"issue":"2","key":"5694_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.lungcan.2015.07.012","volume":"90","author":"A Kuemmel","year":"2015","unstructured":"Kuemmel A, Simon P, Breitkreuz A (2015) Humoral immune responses of lung cancer patients against the Transmembrane Phosphatase with TEnsin homology (TPTE). Lung Cancer 90(2):334\u2013341. https:\/\/doi.org\/10.1016\/j.lungcan.2015.07.012","journal-title":"Lung Cancer"},{"issue":"7","key":"5694_CR16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nrurol.2012.117","volume":"9","author":"P Kulkarni","year":"2012","unstructured":"Kulkarni P, Shiraishi T, Rajagopalan K et al (2012) Cancer\/testis antigens and urological malignancies. Nat Rev Urol 9(7):386\u2013396. https:\/\/doi.org\/10.1038\/nrurol.2012.117","journal-title":"Nat Rev Urol"},{"issue":"2","key":"5694_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cub.2006.12.026","volume":"17","author":"NR Leslie","year":"2007","unstructured":"Leslie NR, Yang X, Downes CP et al (2007) PtdIns (3, 4, 5) P3-dependent and-independent roles for PTEN in the control of cell migration. Curr Biol 17(2):115\u2013125. https:\/\/doi.org\/10.1016\/j.cub.2006.12.026","journal-title":"Curr Biol"},{"issue":"7","key":"5694_CR18","doi-asserted-by":"publisher","first-page":"341.e9","DOI":"10.1016\/j.urolonc.2018.04.003","volume":"36","author":"K Matsumoto","year":"2018","unstructured":"Matsumoto K, Niwa N, Hattori S et al (2018) Establishment of the optimal follow-up schedule after radical prostatectomy. Urol Oncol Semin Orig 36(7):341.e9-341.e14. https:\/\/doi.org\/10.1016\/j.urolonc.2018.04.003","journal-title":"Urol Oncol Semin Orig"},{"key":"5694_CR19","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00262-013-1463-1","volume":"62","author":"M Mohsenzadegan","year":"2013","unstructured":"Mohsenzadegan M, Madjd Z, Asgari M et al (2013) Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis. Cancer Immunol Immunother 62:1609\u20131618. https:\/\/doi.org\/10.1007\/s00262-013-1463-1","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"5694_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2217\/bmm.14.106","volume":"9","author":"M Mohsenzadegan","year":"2015","unstructured":"Mohsenzadegan M, Shekarabi M, Madjd Z et al (2015) Study of NGEP expression pattern in cancerous tissues provides novel insights into prognostic marker in prostate cancer. Biomark Med 9(4):391\u2013401. https:\/\/doi.org\/10.2217\/bmm.14.106","journal-title":"Biomark Med"},{"issue":"2","key":"5694_CR21","first-page":"92","volume":"2","author":"S Nandana","year":"2014","unstructured":"Nandana S, Chung LWK (2014) Prostate cancer progression and metastasis: potential regulatory pathways for therapeutic targeting. Am J Clin Exp Urol 2(2):92 (PMC42193033)","journal-title":"Am J Clin Exp Urol"},{"issue":"6","key":"5694_CR22","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/cells12060926","volume":"12","author":"DS Nin","year":"2023","unstructured":"Nin DS, Deng LW (2023) Biology of cancer-testis antigens and their therapeutic implications in cancer. Cells 12(6):926. https:\/\/doi.org\/10.3390\/cells12060926","journal-title":"Cells"},{"key":"5694_CR23","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1245\/s10434-020-09326-4","volume":"28","author":"CJ Rygalski","year":"2021","unstructured":"Rygalski CJ, Zhao S, Eskander A et al (2021) Time to surgery and survival in head and neck cancer. Ann Surg Oncol 28:877\u2013885. https:\/\/doi.org\/10.1245\/s10434-020-09326-4","journal-title":"Ann Surg Oncol"},{"issue":"7823","key":"5694_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","volume":"585","author":"U Sahin","year":"2020","unstructured":"Sahin U, Oehm P, Derhovanessian E et al (2020) An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. Nature 585(7823):107\u2013112. https:\/\/doi.org\/10.1038\/s41586-020-2537-9","journal-title":"Nature"},{"issue":"7","key":"5694_CR25","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/08820139.2016.1197241","volume":"45","author":"A Salmaninejad","year":"2016","unstructured":"Salmaninejad A, Zamani MR, Pourvahedi M et al (2016) Cancer\/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers. Immunol Invest 45(7):619\u2013640. https:\/\/doi.org\/10.1080\/08820139.2016.1197241","journal-title":"Immunol Invest"},{"issue":"9","key":"5694_CR26","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.3390\/cells9092116","volume":"9","author":"R Saoud","year":"2020","unstructured":"Saoud R, Heidar NA, Cimadamore A et al (2020) Incorporating prognostic biomarkers into risk assessment models and TNM staging for prostate cancer. Cells 9(9):2116. https:\/\/doi.org\/10.3390\/cells9092116","journal-title":"Cells"},{"key":"5694_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.yexmp.2019.04.015","volume":"108","author":"S Shafiei","year":"2019","unstructured":"Shafiei S, Kalantari E, Zanjani LS et al (2019) Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas. Exp Mol Pathol 108:164\u2013172. https:\/\/doi.org\/10.1016\/j.yexmp.2019.04.015","journal-title":"Exp Mol Pathol"},{"issue":"6","key":"5694_CR28","doi-asserted-by":"publisher","first-page":"e1285","DOI":"10.1038\/cddis.2014.244","volume":"5","author":"B Shang","year":"2014","unstructured":"Shang B, Gao A, Pan Y et al (2014) CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis. Cell Death Dis 5(6):e1285\u2013e1285. https:\/\/doi.org\/10.1038\/cddis.2014.244","journal-title":"Cell Death Dis"},{"issue":"2","key":"5694_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1072-7515(03)00332-6","volume":"197","author":"M Shoup","year":"2003","unstructured":"Shoup M, Stojadinovic A, Nissan A et al (2003) Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg 197(2):191\u2013197. https:\/\/doi.org\/10.1016\/S1072-7515(03)00332-6","journal-title":"J Am Coll Surg"},{"issue":"1","key":"5694_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2007.09.018","volume":"259","author":"AP Singh","year":"2008","unstructured":"Singh AP, Bafna S, Chaudhary K et al (2008) Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells. Cancer Lett 259(1):28\u201338. https:\/\/doi.org\/10.1016\/j.canlet.2007.09.018","journal-title":"Cancer Lett"},{"issue":"6","key":"5694_CR31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41568-019-0142-8","volume":"19","author":"S Srivastava","year":"2019","unstructured":"Srivastava S, Koay EJ, Borowsky AD (2019) Cancer overdiagnosis: a biological challenge and clinical dilemma. Nat Rev Cancer 19(6):349\u2013358. https:\/\/doi.org\/10.1038\/s41568-019-0142-8","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"5694_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5694_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre LA, Siegel RL, Ward EM et al (2016) Global cancer incidence and mortality rates and trends\u2014an updateglobal cancer rates and trends\u2014an update. Cancer Epidemiol Biomarkers Prev 25(1):16\u201327. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0578","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"5694_CR34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1042\/bj3600277","volume":"360","author":"SM Walker","year":"2001","unstructured":"Walker SM, Downes CP, Leslie NR (2001) TPIP: a novel phosphoinositide 3-phosphatase. Biochem J 360(2):277\u2013283. https:\/\/doi.org\/10.1042\/bj3600277","journal-title":"Biochem J"},{"key":"5694_CR35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.canlet.2019.10.024","volume":"479","author":"R Wei","year":"2020","unstructured":"Wei R, Dean DC, Thanindratarn P et al (2020) Cancer testis antigens in sarcoma: expression, function and immunotherapeutic application. Cancer Lett 479:54\u201360. https:\/\/doi.org\/10.1016\/j.canlet.2019.10.024","journal-title":"Cancer Lett"},{"issue":"5","key":"5694_CR36","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.3892\/etm.2019.7998","volume":"18","author":"Q Wu","year":"2019","unstructured":"Wu Q, Cao R, Chen J et al (2019) Screening and identification of biomarkers associated with clinicopathological parameters and prognosis in oral squamous cell carcinoma. Exp Ther Med 18(5):3579\u20133587. https:\/\/doi.org\/10.3892\/etm.2019.7998","journal-title":"Exp Ther Med"},{"issue":"10","key":"5694_CR37","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.2174\/1381612821666141211154707","volume":"21","author":"P Yang","year":"2015","unstructured":"Yang P, Huo Z, Liao H et al (2015) Cancer\/testis antigens trigger epithelial-mesenchymal transition and genesis of cancer stem-like cells. Curr Pharm Des 21(10):1292\u20131300. https:\/\/doi.org\/10.2174\/1381612821666141211154707","journal-title":"Curr Pharm Des"},{"issue":"11","key":"5694_CR38","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.3390\/molecules28114370","volume":"28","author":"X Yang","year":"2023","unstructured":"Yang X, Zhang S, Lin N (2023) Application of metal-based nanomaterials in in vitro diagnosis of tumor markers: summary and prospect. Molecules 28(11):4370. https:\/\/doi.org\/10.3390\/molecules28114370","journal-title":"Molecules"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05694-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05694-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05694-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T11:12:24Z","timestamp":1713006744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-05694-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["5694"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-05694-6","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the Ethics Committee of Iran University of Medical Sciences (IR.IUMS.REC.1398.956).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"165"}}